VIVUS Reports First Quarter 2014 Financial Results
[Marketwired] – VIVUS, Inc. , a biopharmaceutical company commercializing Qsymia® capsules CIV for the treatment of obesity, today reported its financial results for the first quarter ended March 31, 2014… more
View todays social media effects on VVUS
View the latest stocks trending across Twitter. Click to view dashboard